New

Turn ETF ideas into real portfolios. Try the builder now →

Advertisement
Advertisement

Corgi Genomics & Precision Medicine ETF

This ETF provides exposure to Other Equities

GNMX performance and flow charts

Last price
N/A
N/A

Performance

0510%Aug 10Aug 17Aug 24Aug 31Sep 7

Flows

0 M0.2 M0.4 M0.6 M0.8 M1 M
1 day price range
N/A
52 week price range
$24.04
$36.55
1W perf
-3.63%
YTD perf
 
YTD flows
-
AuM
$3M
E/R
0.35%
TTM yield
-
Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

Historic performance and flows

Data as of September 9, 2026
1M3MYTD1Y3Y5Y
Perf.+6.36%+29.48%
Flows+$1M+$761K----
Data as of September 9, 2026
Advertisement

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Characteristics

This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.

Management strategyActive
StrategyLong Only
ProviderCorgi Funds
N° of holdings57
Dividend policyDistributing
Inception dateMay 6, 2026
ESGNo
TrackinsightTrackinsight

More data and info about GNMX on Trackinsight

Exposure

Data as of July 31, 2026

Diversification

55.56%

Total weight of top 15 holdings out of 57

Top 15 Holdings

Thermo Fisher Scientific, Inc.
9.28%
Vertex Pharmaceuticals, Inc.
6.75%
Illumina, Inc.
4.56%
Guardant Health, Inc.
4.26%
Revolution Medicines, Inc.
3.92%
Incyte Corp.
3.38%
Moderna, Inc.
3.06%
Genmab A/S
2.96%
Alnylam Pharmaceuticals, Inc.
2.77%
Bio-Techne Corp.
2.67%
10X Genomics, Inc.
2.58%
BioMarin Pharmaceutical, Inc.
2.55%
Arrowhead Pharmaceuticals, Inc.
2.34%
Krystal Biotech, Inc.
2.3%
QIAGEN NV
2.18%

Sectors

Healthcare
96.78%
Other
3.22%

Countries

USA
87.58%
Other
12.42%
Advertisement

Trading data

Last sale
N/A
Previous close
N/A
Consolidated volume
09/09/2026
Join for free
Average volume
30 days
Join for free
Average discount or premium
30 days
Join for free
Average Bid/Ask spread
30 days
Join for free

Volatility and drawdown

3M1Y3Y5Y
Volatility+33.36%
Max drawdown
-8.53%
Max drawdown duration
32dN/AN/AN/A
Time to recover
19dN/AN/AN/A
Frequently asked questions about GNMX

What type of ETF is GNMX?

GNMX is a Active ETF that provides exposure to Equity assets. It is managed by Corgi Funds.

What does GNMX invest in?

This ETF provides exposure to Other Equities. It is part of the segment: BioTech & Genomics.

What is the expense ratio of GNMX?

The total expense ratio (TER) of GNMX is 0.35%, representing the annual fee charged by the fund manager.

When was GNMX launched?

GNMX was launched on May 6, 2026, marking its entry into the ETF market.

Who is the issuer of GNMX?

GNMX is issued by Corgi Funds.

What is the AUM of GNMX?

As of September 9, 2026, GNMX manages $2.58 M, reflecting the total assets held in the fund.

How many holdings are in GNMX

As of July 31, 2026, GNMX holds 57 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.

How diversified is GNMX?

As of July 31, 2026, GNMX holds 57 securities, with 55.56% of its assets concentrated in its top 15 holdings.

What are the top holdings of GNMX?

As of July 31, 2026, GNMX holds a portfolio of 57 underlyings, with its largest positions including Thermo Fisher Scientific, Inc., Vertex Pharmaceuticals, Inc. and Illumina, Inc.. These top holdings play a significant role in shaping the fund’s performance and exposure.

What countries or regions does GNMX invest in?

As of July 31, 2026, GNMX has its largest geographic exposures in USA.

What sectors or themes does GNMX focus on?

As of July 31, 2026, GNMX is primarily exposed to Healthcare.

The ETF Institute® is now affiliated with ETF Central

The CETF certification is the only FINRA listed professional designation focused on ETFs.

ETF Institute
Advertisement
Advertisement
ETF U
Become a better investor with NYSE: The Home of ETFs
Visit the ETF U homepage
ETF Guides
Advertisement

Recent educational content

Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs September 8, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · September 9, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs August 31, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · September 1, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs August 24, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · August 24, 2026
What's the Fund | Ocean Park Diversified Income ETF (DUKZ)

What’sTheFund

What's the Fund | Ocean Park Diversified Income ETF (DUKZ)

James St Aubin, Chief Investment Officer at Ocean Park Asset Management, discuss the DUKZ ETF, exposing investors to the whole spectrum of asset classes in the fixed income markets, through their rules-based process.

NYSE logo
By NYSE · August 18, 2026

Browse all educational columns

ETF INVESTOR RESOURCES

Expert-Built ETF Portfolios, All in One Place

Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.

Portfolio Builder